Kaiser Permanente-Cadillac — Los Angeles, California

Public research footprint of Kaiser Permanente-Cadillac, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Squamous Cell Lung Carcinoma · Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Stage IV Lung Cancer AJCC v8 · Stage IVA Lung Cancer AJCC v8

Recently updated registry entries

NCT03253848 — Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute… (Active Not Recruiting)
NCT03516942 — Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer… (Active Not Recruiting)
NCT00693992 — Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Kaiser Permanente-Cadillac?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.